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The innate immune system surveys the extra- and intracellular environment for the presence of microbes. Among
the intracellular sensors is a protein known as Nod2, a cytosolic protein containing a leucine-rich repeat domain.
Nod2 is believed to play a role in determining host responses to invasive bacteria. A key element in upregulating host
defense involves activation of the NF-B pathway. It has been suggested through indirect studies that NF-B-
inducing kinase, or NIK, may be involved in Nod2 signaling. Here we have used macrophages derived from primary
explants of bone marrow from wild-type mice and mice that either bear a mutation in NIK, rendering it inactive,
or are derived from NIK/ mice, in which the NIK gene has been deleted. We show that NIK binds to Nod2 and
mediates induction of specific changes induced by the specific Nod2 activator, muramyl dipeptide, and that the role
of NIK occurs in settings where both the Nod2 and TLR4 pathways are activated by their respective agonists.
Specifically, we have linked NIK to the induction of the B-cell chemoattractant known as BLC and suggest that this
chemokine may play a role in processes initiated by Nod2 activation that lead to improved host defense.
The innate immune system detects the presence of microor-
ganisms and some viruses using transmembrane and cytosolic
receptors with specificities for distinct components of the infec-
tious agents. Members of the Toll-like receptor (TLR) family are
well recognized for this function (1–3). A second family known as
the Nod/CATERPILLAR protein family includes at least two
proteins, Nod1 (Card4) and Nod2 (Card15), that recognize sub-
structures present in bacterial peptidoglycans (10, 12). Nod2 has
been shown to be involved in genetically determined human dis-
eases; mutations in Nod2 have been linked to susceptibility to
Crohn’s disease and to Blau’s syndrome (10, 12). Crohn’s disease
and Blau’s syndrome are chronic diseases with autoinflammatory
and autoimmune components. Although Nod2 was initially
thought to be a receptor for bacterial lipopolysaccharide (LPS),
more recent studies have shown that Nod2-expressing cells re-
spond to peptidoglycan-derived structures including muramyl
dipeptides (MDP) (9, 13). Whether or not direct binding between
MDP and Nod2 occurs has yet to be determined, despite the fact
that there are extensive structure-function data for Nod2 re-
sponses to MDP (22).
Because of the well-characterized role of NF-B activation
in inflammation, we felt that a more in-depth analysis of MDP-
induced NF-B activation might enhance our understanding of
how Nod2 regulates host responses to bacteria. There are two
major pathways of NF-B activation, known as the canonical
(classical) and noncanonical (alternative) activation pathways.
To date, studies of Nod2 signaling have been focused on the
canonical NF-B pathway, with essentially no direct studies of
the role of the noncanonical pathway (4, 6). Functional char-
acterization of Nod2 demonstrated a role for RIP2 (RICK) in
Nod2-dependent NF-B activation with the use of cells from
RIP2-deficient mice (7, 14). In contrast Nod2 signaling is in-
dependent of adaptor proteins such as MyD88 (18) and Trif
(R. J. Ulevitch et al., unpublished data) required for TLR
signaling. The noncanonical NF-B activation pathway in-
volves NF-B-inducing kinase (NIK), IB kinase  (IKK1),
and p100 leading to cleavage of p100 and formation of p52:
RelB dimmers (4, 8, 23, 24). Here we have examined a possible
role for NIK in Nod2-dependent signaling. Using bone mar-
row-derived macrophages from mice with a targeted deletion
or mutation of NIK, we show that NIK participates in several
Nod2-dependent cellular responses to MDP. Importantly,
these data provide new information about the downstream
signaling pathways of Nod2 and may help us to further under-
stand the role of Nod2 in health and disease.
MATERIALS AND METHODS
Mice and reagents. aly/ (aly heterozygous) and aly/aly (aly homozygous) mice
(17) were purchased from CLEA, Osaka, Japan. NIK/ mice were generously
provided by Tularik Inc. (South San Francisco, CA) (24); Nod2/ mice were
obtained from Koichi Kobayashi and Richard Flavell (Yale University School of
Medicine, New Haven, Conn.) (15). All experimental protocols involving use of
mice were reviewed and approved by the TSRI Institutional Animal Care and
Use Committee.
MDP was purchased from Sigma; LPS isolated from Escherichia coli O111:B4
was purchased from List Biological Laboratories. CpG oligodeoxynucleotide
1826 (TCCATGACGTTCCTGACGTT) was ordered from Sigma-Genosys.
Preparation of bone marrow-derived macrophages (BMDM). Femors and
tibia were collected aseptically from euthanized mice, and after removal of
muscle, the ends of the bones were cut off and the marrow was flushed out using
5-ml syringes with 25-gauge needles and RPMI 1640 medium containing 10%
* Corresponding author. Mailing address: Department of Immunol-
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heat-inactivated (56°C for 30 min) HyClone defined fetal bovine serum (FBS), 2
mM L-glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin. The cells
were spun at 1,000 rpm for 10 min and resuspended in Dulbecco’s modified
Eagle medium (DMEM; Gibco) (with 4.5 g of D-glucose and 110 mg of sodium
pyruvate per liter and with the addition of 30% L929 cell-conditioned medium,
10% heat-inactivated FBS, 2 mM L-glutamine, 100 U/ml penicillin, 100 g/ml
streptomycin), and 30-ml aliquots were added to 150-mm-style non-tissue cul-
ture-treated dishes (Fisher 08-757-14K). The plates were placed in a tissue
culture incubator in 10% CO2 at 37°C, and after 4 days 10 ml of additional
medium was added. When cells reached confluence (typically after 5 to 7 days in
culture), the medium was removed, and the cells were washed once and detached
by a 15-min exposure to ice-cold Dulbecco’s phosphate-buffered saline (PBS)
without calcium or magnesium (Gibco). The detached cells were suspended by
pipetting, centrifuged at 1,000 rpm for 5 min, resuspended in DMEM-L929
conditioned medium, and plated in tissue culture plates. Typically, the cell yield
from one mouse was initially plated in three 150-mm plates, yielding 1 108 cells
after 5 to 7 days in culture. The cells were observed to be 94% CD11b positive
by fluorescence-activated cell sorting analysis. The BMDM were plated at 1 
106 cells per ml in 24-well tissue culture plates 18 h prior to use in experiments.
L929 conditioned medium was produced by plating L929 cells (ATCC CCL-1) in
150-cm2 tissue culture flasks at an initial density of 1 106 cells per ml in DMEM
(high glucose) supplemented with 10% nonheated FBS, 2 mM L-glutamine, and
penicillin/streptomycin as described above. After 5 to 7 days in culture, when the
adherent cells were fully confluent, the culture supernatant was centrifuged at
2,000 rpm for 10 min, aliquoted in 50-ml tubes, and stored at 20°C.
RNA quantification. Total RNA was isolated using Trizol reagent (Invitrogen
Inc.), and 1 g of RNA was reverse transcribed using Superscript II (Invitrogen
Inc.). Real-time PCR was done in an Applied Biosystems HT7900 using a SYBR
Green detection protocol. The following primers were used to amplify specific
genes: B lymphocyte chemoattractant (BLC) 5, CCCCAAAACTGAAGTTGT
GATCT, and BLC 3, CAGGCAGCTCTTCTCTTACTCACT; RANTES 5,
GCCCACGTCAAGGAGTATTTCTA, and RANTES 3, ACACACTTGGCG
GTTCCTTC; 18sRNA 5, CCGCGGTTCTATTTTGTTGGT, and 18sRNA 3,
CTCTAGCGGCGCAATACGA; interleukin-1	 (IL-1	) 5, GCAACTGTTCC
TGAACTCAACT, and IL-1	 3, ATCTTTTGGGGTCCGTCAACT.
Immunoprecipitation and Western blot analysis. For immunoprecipitation
experiments, HEK 293 cells were transfected with Lipofectamine 2000 (Life
Technologies, Inc.) and cultured for an additional 24 h. Cells were suspended in
lysis buffer (225 mM NaCl, 50 mM Tris 7.4, 1% NP-40, supplemented with
Protease Inhibitor Cocktail Set III [CalBiochem Inc.]) for 30 min at 4°C. Cell
lysates were centrifuged at 14,000 rpm for 5 min, and supernatants were first
preincubated with protein G-Sepharose beads for 2 h and spun at 13,000 rpm for
5 min. The supernatants were collected and incubated with anti-FLAG antibody
(2 g/ml; Santa Cruz Biotechnology) and protein G beads overnight at 4°C. The
precipitated immunocomplex was washed five times with lysis buffer and sepa-
rated by sodium dodecyl sulfate–10% polyacrylamide gel electrophoresis (SDS–
10% PAGE). Proteins were transferred to Immobilon-P (polyvinylidene di-
fluoride) membranes (Millipore). The membrane was blocked with a solution
containing PBS (PH 7.4), 0.5% Tween 20, and 5% nonfat milk. Incubation with
anti-Myc mouse monoclonal antibody (clone 9E10, 1:2,000 dilution; Santa Cruz
Biotechnology) was carried out at room temperature overnight. The blot was
developed with ECL Plus reagent (Amersham Bioscience). For detection of
NF-B2 protein, cells were stimulated as indicated in the figure legends and lysed
directly with SDS loading buffer. Cell lysates were separated on SDS–10%
PAGE gels, and NF-B proteins were detected with antibody which recognized
both p100 and p52 (at a dilution of 1:2,000; anti-human p100 [Upstate Biotech]
or anti-murine p100 [Santa Cruz Biotechnology]). Antitubulin antibody (Santa
Cruz Biotechnology Inc., CA) was used as a gel loading control.
Preparation of nuclear extracts. Cells (2  106) were washed with ice-cold
PBS and resuspended in 0.4 ml of buffer A (10 mM HEPES, pH 7.9, 10 mM KCl,
0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol, 0.5 mM phenylmethyl-
sulfonyl fluoride). After 10 min, Nonidet P-40 was added to 0.6%. Nuclei were
separated from the cytosol by centrifugation at 13,000  g for 10 seconds and
resuspended in 50 l of buffer B (20 mM HEPES, pH 7.9, 0.4 M NaCl, 1 mM
EDTA, 1 mM EGTA, 0.1 mM phenylmethylsulfonyl fluoride). After 30 min at
FIG. 1. NIK interacts with Nod2. (A) MDP induces p100 process-
ing in a Nod2-dependent manner. HEK 293 cells were transfected with
100 ng of p100 expression construct in combination with different
amounts of Myc-tagged Nod2 expression plasmid. Cells were stimu-
lated with 20 g/ml MDP for 24 h, and p100 processing was detected
with anti-NF-B2 monoclonal antibody, which recognizes both p100
and p52. Myc-tagged Nod2 protein was detected by anti-Myc immuno-
blotting. The film was scanned, and the band intensity of p52 was
calibrated as described in Materials and Methods. (B and C) Interac-
tion of NIK with Nod2. HEK 293 cells were cotransfected with Myc-
tagged Nod2 (B) or truncated Myc-tagged Nod2
CARD (C) and with
FLAG-tagged NIK, RIP, RICK, and p38 expression plasmids. The cell
lysates were immunoprecipitated with rabbit polyclonal anti-FLAG
antibody overnight. The resulting immune complexes were fraction-
ated by SDS-PAGE, transferred to membranes, and subsequently
probed with monoclonal anti-Myc antibody. The lysates (10% of im-
munoprecipitation input) derived from each transfection were also
loaded in gels as control and immunoblotted using anti-FLAG and
anti-Myc antibodies.
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4°C, lysates were centrifuged at 13,000  g for 30 s, and the supernatant con-
taining nuclear proteins was collected.
Quantitation of Western blot band intensities. Western blot films were
scanned with a GS-800 Densitometer (Bio-Rad). The band intensity was pre-
sented as density (optical density [OD]/mm2) and normalized by the ratio of
tubulin band density.
Measurement of cytokine production. The concentrations of BLC, macrophage-
derived chemokine (MDC), IL-6, and tumor necrosis factor  (TNF-) in culture
supernatants of BMDM were measured by enzyme-linked immunosorbent assay
(ELISA) using reagents purchased from R&D, Inc. (Minneapolis, MN).
Helicobacter felis culture and infection.H. felis (ATCC 49179) was grown under
microaerobic conditions in a BBL Campy Pouch microaerophilic system (catalog
no. 260656; Becton Dickinson) containing N2, H2, and CO2 (80:10:10) at 37°C on
brucella broth agar plates supplemented with 5% sheep blood. The bacteria were
harvested after 24 to 48 h of growth, washed, and resuspended in PBS. The OD
at 600 nm (OD600) was determined, and the bacteria titer was calculated (1 108
FIG. 2. Essential roles of Nod2 and NIK in mediating responses to MDP and LPS. (A) Nod2 mediates MDP-induced IB degradation and
p38 phosphorylation. Nod2/ and Nod2/ BMDM were stimulated with MDP (20 g/ml) or LPS (10 ng/ml) for different times. Cell lysates were
prepared, and IB degradation and p38 phosphorylation were detected by Western blotting using specific antibodies. NIK (B and C) and Nod2
(D) are required for synergistic production of p52 by MDP and LPS. BMDM from aly/ and aly/aly mice lacking functional NIK (B) or BMDM
from NIK/ and NIK/ mice (C) and also BMDM from WT and Nod2/ mice (D) were stimulated by various concentrations of LPS in the
presence or absence of MDP (20 g/ml) for 24 h, and processing of p100 was analyzed by Western blotting using anti-NF-B2 antibody recognizing
both p100 and p52. The films were scanned, and the band density for p52 was normalized to the tubulin constitutive control.
FIG. 3. NIK regulates LPS- and CpG-induced p52 nuclear translocation. BMDM were stimulated with LPS (100 ng/ml) and CpG (0.2 M) for
the indicated time points. Cells were lysed, and nuclear fractions were subjected to Western blot analysis with the indicated antibody.




arch 3, 2014 by W







CFU per OD unit). The presence of H. felis was confirmed by characteristic
colony morphology, motility, and a urease test. BMDM were infected by bacteria
for 24 h in the absence of antibiotics, and cell culture supernatants were assayed
for specific cytokine secretion.
Statistical analysis. A Student’s t test (two-tailed) was used to evaluate the
data. A P value of 0.05 was considered significant.
RESULTS
p52 production via Nod2. In order to determine if activation
of the Nod2 pathway leads to events associated with the non-
canonical NF-B pathway, we focused our efforts on the role of
the enzyme known as NIK. NIK is critical for the processing of
p100 to p52 (4). Mammalian cells express five NF-B proteins:
NF-B1 (the DNA-binding subunit p50 and its precursor
p105), NF-B2 (the DNA-binding subunit p52 and its precur-
sor p100), RelA (p65), RelB, and c-Rel. NF-B1 is critical for
the canonical pathway, while processing of p100 activates non-
canonical pathway. We first sought to determine whether
MDP-induced cell activation leads to Nod2-dependent p52
production. To address this question, we transiently expressed
p100 and Nod2 in HEK 293 cells and asked whether we could
detect MDP- and Nod2-dependent p52 production. p52 accu-
mulation was observed when MDP was added to Nod2-trans-
fected cells, supporting a link between MDP, Nod2, and the
NIK pathway (Fig. 1A). In studies not shown, we also noted
that p52 was found in the nucleus of MDP-treated cells. Fur-
ther, we observed constitutive production of p52 with the high-
est input of Nod2 cDNA, in keeping with ligand-independent
activation of Nod2 when it is overexpressed (Fig. 1A). Several
lines of evidence show that RIP2/RICK is important for Nod2
activation of the canonical NF-B pathway and that it binds to
Nod2 via CARD-CARD domain interactions (14, 18). RIP2 is
upstream of the IKK1/IKK2 pathway, while NIK is upstream of
IKK1 in the noncanonical pathway. We next asked if we could
detect interactions of NIK and Nod2. We coexpressed FLAG-
tagged constructs encoding RIP, RIP2, NIK, and p38 with
Myc-tagged wild-type Nod2 or Nod2 containing deletions in
the CARD domain (Nod2
CARD) in HEK 293 cells; cell
lysates were immunoprecipitated with anti-FLAG, and the re-
sulting immunoprecipitates were resolved by SDS-PAGE and
visualized by Western blotting with anti-Myc antibody. We
observed that both RIP2 and NIK, but not RIP or p38, inter-
acted with wild-type Nod2 (Fig. 1B) and that NIK but not RIP2
interacted with NOD2
CARD (Fig. 1C). Thus, Nod2 appears
to utilize CARD domain-dependent and -independent inter-
actions to transduce signals to the canonical and noncanonical
NF-B pathways. In studies not shown, we also determined
that NIK binds similarly to wild-type Nod2 or Nod2 containing
various mutations (R702W, P268S, G908R, or the frameshift
mutation L1007fsinsC), which are often found in Crohn’s dis-
ease patients (12).
Pathway requirements for p52 production. We next used
BMDM from Nod2/, NIK/, and aly/aly strains of mice to
further study the role of NIK in MDP signaling. The aly/aly
strain has a point mutation in NIK that renders NIK inactive
while aly/ strain has a wild-type phenotype (23). It is now well
established that Nod2 does not recognize LPS but, rather, is a
receptor for structures found in bacterial peptidoglycans such
as MDP. It is very likely that in physiological settings, a variety
of TLR ligands might be present that influence Nod2 signaling
via TLR activation pathways. In support of this concept are
multiple studies showing synergies between TLR and Nod2
signaling. Here we have used LPS as a prototypic TLR4 acti-
vator and examined its effects in combination with MDP-in-
FIG. 4. Impaired BLC gene induction in NIK/ cells. BMDM
were stimulated for 24 h with LPS (0.02 to 0.4 ng/ml) and 20 g/ml
MDP. Gene induction (mRNA) was determined by real-time PCR.
The relative expression of genes was normalized to the level of 18s
RNA. Data are presented as means  standard deviations of triplicate
wells. , P  0.01 for cytokine concentrations from knockout mice
compared with data from wild-type mice. Results are representative of
two independent experiments.
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duced Nod2 signaling. BMDM from Nod2/ and Nod2/
mice were treated with MDP or LPS, and subsequent changes
in IB degradation and p38 activation were measured as
indicators of cell activation. MDP induced IB degradation
and p38 activation in Nod2/ but not Nod2/ cells, while the
LPS responses were identical in Nod2/ and Nod2/
BMDM (Fig. 2A). Thus, the absence of Nod2 does not reduce
LPS responses but completely blunts MDP-induced cell acti-
vation. BMDM derived from aly/aly or NIK/ cells that are
defective in the NIK pathway due to a mutation in the former
and gene deletion in the latter were used to further character-
ize endogenous Nod2 signaling pathways. Specifically, we de-
termined how MDP, LPS, or the combination of the two in-
fluenced processing of p100 to p52 in wild-type or mutant cell
lines. Addition of MDP alone produced barely detectable p52,
but when increasing amounts of LPS were added to aly/ cells,
a synergistic production of p52 was observed (Fig. 2B). In
addition we observed that MDP or LPS alone or when added
together produced a strong increase in p100 production. When
we compared aly/ and aly/aly cells, we observed that the
enhanced p52 production noted when MDP and LPS were
added together was absent in the aly/aly cells homozygous for
the NIK mutation. In contrast, the marked increase in p100
protein expression induced by MDP, LPS, or the combination
of the two occurred to a similar extent when responses in aly/
and aly/aly cells were compared. We also observed a compa-
rable response pattern when MDP and LPS were added to-
gether to NIK/ or NIK/ BMDM. NIK/ cells treated
with LPS and MDP showed enhanced, synergistic production
of p52 that was not observed with the NIK/ BMDM (Fig.
2C). In contrast, increases in p100 expression were identical in
NIK/ and NIK/ BMDM. The synergy between LPS and
MDP required the presence of Nod2 since we observed en-
hanced p52 production when MDP and LPS were added to
Nod2/ cells but not when we performed the identical exper-
iment using Nod2/ BMDM (Fig. 2D). Thus, the totality of
the data provided here support the contention that MDP sig-
nals via both the canonical and noncanonical NF-B pathways
and requires NIK for multiple and distinct responses in both
transfected cell lines and in primary cell isolates and that
synergies exist as shown here by the enhanced responses trig-
gered by the combined effects of MDP and LPS.
To determine if NIK is also required for p52 generation and
subsequent translocation in cells activated by other TLR acti-
vators, BMDM were challenged with LPS (100 ng/ml) and
CpG (0.2 mM), and nuclear fractions were subjected to immu-
noblot analyses. Both LPS and CpG induced p52 generation in
wild-type but not NIK/ cells. In contrast, translocation of other
members of NF-B family (RelA, p50, and cRel) were found in
approximately equal amounts in wild-type and NIK/ cells nor-
mally (Fig. 3).
NIK-dependent gene induction via the Nod2 pathway. We
next performed an expression analysis on total RNA from
resting and activated BMDM obtained from wild-type and
NIK/ mice comparing the effects of stimulation with MDP,
LPS, and MDP plus LPS to determine if we could identify one
FIG. 5. Diminished BLC secretion in NIK/ cells. BMDM were stimulated for 24 h (LPS, 0.04 ng/ml; MDP, 20 g/ml) and the production
of cytokine and chemokine were determined by specific ELISA. Data are presented as means  standard deviations of triplicate wells. , P 0.05,
and , P  0.01, for cytokine concentrations from knockout mice compared with data from wild-type mice. Results are representative of three
independent experiments.
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or more genes that are selectively upregulated by the combi-
nation of LPS and MDP compared to the effects of either
ligand alone. Analysis of the arrays to be presented elsewhere
(R. J. Ulevitch, Q. Pan, C. Fearns, et al., unpublished data)
revealed that the gene encoding BLC (CXCL13) was strongly
upregulated by the combined effects of LPS and MDP in wild-
type but not NIK/ cells. Based on these findings, we con-
ducted experiments to quantify BLC, RANTES, and IL-1	
mRNA expression by reverse transcription-PCR in BMDM
from wild-type or NIK/ mice following stimulation by LPS,
MDP, or LPS plus MDP. Results shown in Fig. 4 demonstrate
that BLC mRNA expression is markedly upregulated in wild-
type but not NIK/ BMDM when LPS and MDP are added
simultaneously. In contrast, expression of RANTES and IL-1	
mRNA was identical in the parental and NIK/ BMDM.
We also observed strong synergies between LPS and MDP in
secretion of chemokines and proinflammatory cytokines. This
was observed for release of BLC, MDC, TNF-, and IL-6. A
key role for the NIK pathway was only noted for BLC with a
marked reduction in release when wild-type and NIK/
BMDM were compared (Fig. 5). These data reflect the same
pattern of mRNA expression when BLC induction was com-
pared with RANTES and IL-1	. However, the levels of pro-
duction of other cytokines (TNF-, IL-6, and MDC) were
similar in wild-type and NIK/ cells.
To further establish the functional significance of NIK in
innate immunity, we infected BMDM with the gram-negative
bacterium H. felis. H. felis is a mouse gastric pathogen, and
infection of mouse by H. felis mimics many pathogenic changes
commonly found in humans infected with Helicobacter pylori.
Our data showed that H. felis activated murine macrophages
(NIK/ and NIK/) and induced comparable levels of ex-
pression of TNF- and IL-6 in NIK/ and NIK/ macro-
phages (Fig. 6A). In contrast, the absence of NIK resulted in a
decrease in BLC production that was seen both at the protein
(Fig. 6A) and mRNA levels (Fig. 6B).
DISCUSSION
It is our contention that a better understanding of the role of
Nod2 in disease will derive from defining Nod2-dependent
signaling pathways. Few studies have addressed questions
about Nod2 function under physiological conditions where en-
dogenous signal transduction pathways can be studied. Here
we have provided several distinct experimental approaches
that establish a role for NIK in Nod2-dependent signaling and
that support the contention that Nod2 is linked to both the
canonical and noncanonical NF-B pathways. This contention
is supported by studies that show NIK binding to Nod2, MDP-
dependent processing of p100 to p52 requiring both Nod2 and
NIK, and a requirement for NIK in Nod2-dependent induction
of the chemokine encoded by the BLC gene. The requirement
for NIK is not global since induction levels of multiple other
genes including IL-1, TNF, IL-6, and other matrix metallopro-
FIG. 6. Helicobacter infection induced BLC gene activation and chemokine secretion in a NIK-dependent manner. (A) BMDM were infected
with H. felis at the indicated multiplicity of infection (MOI) for 24 h, and induction of cytokines was detected with specific ELISA kits. Data are
presented as means  standard deviations of triplicate wells. Results are representative of three independent experiments. (B) BMDM were
infected with H. felis at the indicated multiplicity of infection (MOI) for 24 h. Relative gene expression was detected by real-time PCR. Data are
presented as means  standard deviations of triplicate wells. , P  0.01 for cytokine concentrations from knockout mice compared with data
from wild-type mice. Results are representative of three independent experiments.
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teinase family members are identical in NIK-sufficient and
NIK-deficient cells. We further showed that there is a striking
synergy between LPS and MDP in activating the noncanonical
NF-B pathway and in gene expression and that in some cases
this synergy requires NIK as well. Previous studies have used
dominant-negative forms of NIK to probe Nod2-dependent
signaling pathways (18). No previous studies have investigated
a role for NIK in primary cell types such as BMDM or under
conditions that reflect signaling via endogenous pathways.
The major role of the noncanonical NF-B pathway in immu-
nology has been assigned to adaptive immunity with a specific
emphasis on its role in the development and maintenance of
secondary lymphoid organs (4). Here we show that the role of
NIK-dependent gene expression is not confined to these latter
responses but include genes and pathways associated with innate
immunity and inflammation. We have identified one specific gene
encoding the chemokine known as BLC. Here we have linked
BLC production to Nod2- and NIK-dependent pathways. BLC is
usually expressed in secondary lymphoid tissue constitutively, and
aberrant expression of BLC has also been associated with chronic
inflammatory diseases, such as H. pylori gastritis (16) and rheu-
matoid arthritis (5, 20). These data suggested an important role
for NIK in innate responses to bacteria infection and associated
chronic disease as well.
The work described here provides a new framework to in-
vestigate the downstream events triggered by Nod2 activation
and to further define the physiological role of Nod2 in health
and disease. Whether the current studies provide the basis to
understand recent results of Hollenbach et al. (11) will require
further work in appropriate animal models. In their study, they
examined the effects of p38 inhibitor SB203580. They showed
the activation of the noncanonical NF-B pathway in a dextran
sulfate sodium-induced murine model of inflammatory bowel
disease. Their studies also suggested that SB203580 could in-
hibit both the canonical and noncanonical NF-B pathways
leading to an improved clinical score in the bowel. Despite
continued uncertainty about the pathogenesis of Crohn’s dis-
ease, the results provided herein may well lead to a novel
means to regulate key events linked to Nod2 signaling. This
would include distinct modulation of the canonical and non-
canonical NF-B pathways as well as the basis for a better
understanding of the influence of mutations in Nod2 or other
genes linked to Crohn’s disease susceptibility (19, 21).
ACKNOWLEDGMENTS
This study was supported in part by the National Institutes of Health
(grants AI15136 and GM28485 to R.J.U. and grant AI058047 to
R.D.S.), Novartis SFP-1475 (R.J.U.), and The Eli and Edythe L. Broad
Foundation (K.K.).
REFERENCES
1. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev.
Immunol. 4:499–511.
2. Beutler, B., K. Hoebe, X. Du, and R. J. Ulevitch. 2003. How we detect
microbes and respond to them: the Toll-like receptors and their transducers.
J. Leukoc. Biol. 74:479–485.
3. Beutler, B., and J. Hoffmann. 2004. Innate immunity. Curr. Opin. Immunol. 16:1–3.
4. Bonizzi, G., and M. Karin. 2004. The two NF-B activation pathways and
their role in innate and adaptive immunity. Trends Immunol. 25:280–288.
5. Carlsen, H. S., E. S. Baekkevold, H. C. Morton, G. Haraldsen, and P.
Brandtzaeg. 2004. Monocyte-like and mature macrophages produce
CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lym-
phoid neogenesis. Blood 104:3021–3027.
6. Chen, C. M., Y. Gong, M. Zhang, and J. J. Chen. 2004. Reciprocal cross-talk
between Nod2 and TAK1 signaling pathways. J. Biol. Chem. 279:25876–
25882.
7. Chin, A. I., P. W. Dempsey, K. Bruhn, J. F. Miller, Y. Xu, and G. Cheng.
2002. Involvement of receptor-interacting protein 2 in innate and adaptive
immune responses. Nature 416:190–194.
8. Fagarasan, S., R. Shinkura, T. Kamata, F. Nogaki, K. Ikuta, K. Tashiro, and
T. Honjo. 2000. Alymphoplasia (aly)-type nuclear factor B-inducing kinase
(NIK) causes defects in secondary lymphoid tissue chemokine receptor sig-
naling and homing of peritoneal cells to the gut-associated lymphatic tissue
system. J. Exp. Med. 191:1477–1486.
9. Girardin, S. E., I. G. Boneca, J. Viala, M. Chamaillard, A. Labigne, G.
Thomas, D. J. Philpott, and P. J. Sansonetti. 2003. Nod2 is a general sensor
of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol.
Chem. 278:8869–8872.
10. Girardin, S. E., and D. J. Philpott. 2004. The role of peptidoglycan recog-
nition in innate immunity. Eur. J. Immunol. 34:1777–1782.
11. Hollenbach, E., M. Neumann, M. Vieth, A. Roessner, P. Malfertheiner, and
M. Naumann. 2004. Inhibition of p38 MAP kinase- and RICK/NF-B-sig-
naling suppresses inflammatory bowel disease. FASEB J. 18:1550–1552.
12. Inohara, N., and G. Nunez. 2003. NODs: intracellular proteins involved in
inflammation and apoptosis. Nat. Rev. Immunol. 3:371–382.
13. Inohara, N., Y. Ogura, A. Fontalba, O. Gutierrez, F. Pons, J. Crespo, K.
Fukase, S. Inamura, S. Kusumoto, M. Hashimoto, S. J. Foster, A. P. Moran,
J. L. Fernandez-Luna, and G. Nunez. 2003. Host recognition of bacterial
muramyl dipeptide mediated through NOD2. Implications for Crohn’s dis-
ease. J. Biol. Chem. 278:5509–5512.
14. Kobayashi, K. S., N. Inohara, L. D. Hernandez, J. E. Galan, G. Nunez, C. A.
Janeway, R. Medzhitov, and R. A. Flavell. 2002. RICK/Rip2/CARDIAK
mediates signalling for receptors of the innate and adaptive immune systems.
Nature 416:194–199.
15. Kobayashi, K. S., M. Chamaillard, Y. Ogura, O. Henegariu, N. Inohara, G.
Nunez, and R. A. Flavell. 2005. Nod2-dependent regulation of innate and
adaptive immunity in the intestinal tract. Science 307:731–734.
16. Mazzucchelli, L., A. Blaser, A. Kappeler, P. Scharli, J. A. Laissue, M.
Baggiolini, and M. Uguccioni. 1999. BCA-1 is highly expressed in Helico-
bacter pylori-induced mucosa-associated lymphoid tissue and gastric lym-
phoma. J. Clin. Investig. 104:1333–1334.
17. Miyawaki, S., Y. Nakamura, H. Suzuka, M. Koba, R. Yasumizu, S. Ikehara,
and Y. Shibata. 1994. A new mutation, aly, that induces a generalized lack of
lymph nodes accompanied by immunodeficiency in mice. Eur. J. Immunol.
24:429–434.
18. Ogura, Y., N. Inohara, A. Benito, F. F. Chen, S. Yamaoka, and G. Nunez.
2001. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes
and activates NF-B. J. Biol. Chem. 276:4812–4818.
19. Peltekova, V. D., R. F. Wintle, L. A. Rubin, C. I. Amos, Q. Huang, X. Gu, B.
Newman, M. Van Oene, D. Cescon, G. Greenberg, A. M. Griffiths, P. H.
George-Hyslop, and K. A. Siminovitch. 2004. Functional variants of OCTN
cation transporter genes are associated with Crohn’s disease. Nat. Genet.
36:471–475.
20. Shi, K., K. Hayashida, M. Kaneko, J. Hashimoto, T. Tomita, P. E. Lipsky, H.
Yoshikawa, and T. Ochi. 2001. Lymphoid chemokine B cell-attracting chemo-
kine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles
within the synovium of chronic arthritis patients. J. Immunol. 166:650–655.
21. Stoll, M., B. Corneliussen, C. M. Costello, G. H. Waetzig, B. Mellgard, W. A.
Koch, P. Rosenstiel, M. Albrecht, P. J. Croucher, D. Seegert, S. Nikolaus, J.
Hampe, T. Lengauer, S. Pierrou, U. R. Foelsch, C. G. Mathew, M. Lagerstrom-
Fermer, and S. Schreiber. 2004. Genetic variation in DLG5 is associated with
inflammatory bowel disease. Nat. Genet. 36:476–480.
22. Tanabe, T., M. Chamaillard, Y. Ogura, L. Zhu, S. Qiu, J. Masumoto, P.
Ghosh, A. Moran, M. M. Predergast, G. Tromp, C. J. Williams, N. Inohara,
and G. Nunez. 2004. Regulatory regions and critical residues of NOD2
involved in muramyl dipeptide recognition. EMBO J. 23:1587–1597.
23. Yamada, T., T. Mitani, K. Yorita, D. Uchida, A. Matsushima, K. Iwamasa,
S. Fujita, and M. Matsumoto. 2000. Abnormal immune function of hemo-
poietic cells from alymphoplasia (aly) mice, a natural strain with mutant
NF-B-inducing kinase. J. Immunol. 165:804–812.
24. Yin, L., L. Wu, H. Wesche, C. D. Arthur, J. M. White, D. V. Goeddel, and
R. D. Schreiber. 2001. Defective lymphotoxin-	 receptor-induced NF-B
transcriptional activity in NIK-deficient mice. Science 291:2162–2165.
Editor: A. D. O’Brien




arch 3, 2014 by W
ashington University in St. Louis
http://iai.asm
.org/
D
ow
nloaded from
 
